Skip to contentA
Aethlon Medical Inc
A
AEMDAethlon Medical Inc Q3 2025 · 10-Q
Revenue—
Net Income-$1.75M-$1.75MN/M vs Q3 2024 EPS Diluted-$10.05-$10.05N/M vs Q3 2024 Operating Income-$1,814,747N/M Operating Cash Flowderived-$2,010,788N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aethlon Medical Inc · CIK 882291 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,012,980N/M ended Dec 31, 2024 · filed Feb 12, 2025 · 43 d after period end